UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000039155 |
|---|---|
| Receipt number | R000044657 |
| Scientific Title | Fpllow-up study of multicenter, prospective, randomised and comparative study of alternative anti-androgen (AA) therapy and early initiating enzalutamide for castration-resistant prostate cancer (CRPC) after combined androgen blockade (CAB) therapy with bicalutamide (OCUU-CRPC follow-up study). |
| Date of disclosure of the study information | 2020/01/21 |
| Last modified on | 2021/10/07 14:59:30 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2020/01/14 17:32:32 | ||
| 2 | Update | 2020/01/23 10:25:50 | Key secondary outcomes Key secondary outcomes |
|
| 3 | Update | 2020/07/16 16:41:02 | Key inclusion criteria Key inclusion criteria Target sample size |
|
| 4 | Update | 2020/07/16 16:41:45 | Number of participants that the trial has enrolled |
|
| 5 | Update | 2021/07/19 12:03:44 | Last follow-up date Date analysis concluded |
|
| 6 | Update | 2021/10/07 14:59:30 | Date of closure to data entry Date trial data considered complete |
